Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Infectious Disease Rapid Diagnostic Testing market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Infectious Disease Rapid Diagnostic Testing market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Infectious Disease Rapid Diagnostic Testing market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Infectious Disease Rapid Diagnostic Testing products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Infectious Disease Rapid Diagnostic Testing products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Infectious Disease Rapid Diagnostic Testing market.
To learn more about this report
Increasing research and development spending on Infectious Disease Rapid Diagnostic Testing development has been the leading industry trend of Infectious Disease Rapid Diagnostic Testing market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Assays, Platforms, Other |
| By Application Outlook | Respiratory Infection, Gastro-Intestinal Infection, Center Nervous System Infection, Hospital Acquired Infection, Sexually Transmitted Infections, Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Abbott Laboratories, Roche Ltd, Danaher Corporation, Luminex Corporation, BGI Group, bioMerieux S.A., DiaSorin S.p.A, Hologic, Inc., Mesa Biotech, Quidel Corporation, Thermo Fisher Scientific Inc., GenMark Diagnostics, CTK Biotech, Becton Dickinson, Cellex Inc. |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Infectious Disease Rapid Diagnostic Testing Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Infectious Disease Rapid Diagnostic Testing Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Infectious Disease Rapid Diagnostic Testing Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Infectious Disease Rapid Diagnostic Testing Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Assays
4.2.2 Platforms
4.2.3 Other
4.4 Type Comparison Matrix
4.5 Global Infectious Disease Rapid Diagnostic Testing Market Attractiveness, By Type
5 Global Infectious Disease Rapid Diagnostic Testing Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Infectious Disease Rapid Diagnostic Testing Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Respiratory Infection
5.3.2 Gastro-Intestinal Infection
5.3.3 Center Nervous System Infection
5.3.4 Hospital Acquired Infection
5.3.5 Sexually Transmitted Infections
5.3.6 Others
5.4 Application Comparison Matrix
5.5 Global Infectious Disease Rapid Diagnostic Testing Market Attractiveness, by Application
6 Global Infectious Disease Rapid Diagnostic Testing Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Infectious Disease Rapid Diagnostic Testing Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Infectious Disease Rapid Diagnostic Testing Market Attractiveness, by Region
8 North America Infectious Disease Rapid Diagnostic Testing Market Analysis and Forecast
8.1 Key Findings
8.2 North America Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Assays
8.2.2 Platforms
8.2.3 Other
8.3 North America Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Respiratory Infection
8.3.2 Gastro-Intestinal Infection
8.3.3 Center Nervous System Infection
8.3.4 Hospital Acquired Infection
8.3.5 Sexually Transmitted Infections
8.3.6 Others
8.4 North America Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Infectious Disease Rapid Diagnostic Testing Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Infectious Disease Rapid Diagnostic Testing Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Assays
9.2.2 Platforms
9.2.3 Other
9.3 Europe Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Respiratory Infection
9.3.2 Gastro-Intestinal Infection
9.3.3 Center Nervous System Infection
9.3.4 Hospital Acquired Infection
9.3.5 Sexually Transmitted Infections
9.3.6 Others
9.4 Europe Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Infectious Disease Rapid Diagnostic Testing Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Assays
10.2.2 Platforms
10.2.3 Other
10.3 Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Respiratory Infection
10.3.2 Gastro-Intestinal Infection
10.3.3 Center Nervous System Infection
10.3.4 Hospital Acquired Infection
10.3.5 Sexually Transmitted Infections
10.3.6 Others
10.4 Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Infectious Disease Rapid Diagnostic Testing Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Assays
11.2.2 Platforms
11.2.3 Other
11.3 Latin America Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Respiratory Infection
11.3.2 Gastro-Intestinal Infection
11.3.3 Center Nervous System Infection
11.3.4 Hospital Acquired Infection
11.3.5 Sexually Transmitted Infections
11.3.6 Others
11.4 Latin America Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Infectious Disease Rapid Diagnostic Testing Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Infectious Disease Rapid Diagnostic Testing Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Assays
12.2.2 Platforms
12.2.3 Other
12.3 Middle East & Africa (MEA) Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Respiratory Infection
12.3.2 Gastro-Intestinal Infection
12.3.3 Center Nervous System Infection
12.3.4 Hospital Acquired Infection
12.3.5 Sexually Transmitted Infections
12.3.6 Others
12.4 Middle East & Africa (MEA) Infectious Disease Rapid Diagnostic Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Infectious Disease Rapid Diagnostic Testing Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Roche Ltd
13.3.3 Danaher Corporation
13.3.4 Luminex Corporation
13.3.5 BGI Group
13.3.6 bioMerieux S.A.
13.3.7 DiaSorin S.p.A
13.3.8 Hologic
13.3.9 Inc.
13.3.10 Mesa Biotech
13.3.11 Quidel Corporation
13.3.12 Thermo Fisher Scientific Inc.
13.3.13 GenMark Diagnostics
13.3.14 CTK Biotech
13.3.15 Becton Dickinson
13.3.16 Cellex Inc.
14 Key Takeaways
Choose License Type